SEC Form 4 · accession 0001179110-15-016162
INVIVO THERAPEUTICS HOLDINGS CORP. · NVIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth DiPietro
Director
Period of report
Dec 10, 2015
Accepted (ET)
Dec 11, 2015 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001292519
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (RIght to Buy)F1 | $7.37 | Dec 10, 2015 | A | 12,500 | A | — | Dec 10, 2025 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1Option vests in 12 equal monthly installments on each monthly anniversary of the date of grant until fully vested on the first anniversary of the date of grant.